509 883

Cited 0 times in

15-deoxy-D12,14-prostaglandin J2 suppresses RANTES expression by inhibiting NADPH oxidase activation in Helicobacter pylori-infected gastric epithelial cells

DC Field Value Language
dc.contributor.author김경환-
dc.date.accessioned2014-12-20T16:47:04Z-
dc.date.available2014-12-20T16:47:04Z-
dc.date.issued2011-
dc.identifier.issn0867-5910-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/93371-
dc.description.abstractPeroxisome proliferators-activated receptor-γ (PPAR-γ) is a ligand-activated transcription factor. 15 deoxy-(12,14) prostaglandin J(2) (15d-PGJ(2)) is a potent PPAR-γ ligand and acts as an anti-inflammatory agent via PPAR-γ-dependent and independent mechanisms. Helicobacter pylori (H. pylori) induces gastric inflammation by inducing the activation of oxidant-sensitive transcription factor NF-κB and cytokine expression in gastric epithelial cells. Since 15d-PGJ(2) inhibits NF-κB activation in various cells, it may suppress H. pylori-induced inflammatory signaling and cytokine expression in gastric epithelial cells. The present study aims to determined the effect of 15d-PGJ(2) on the activation of inflammatory mediators Jak/Stat (Janus kinase/signal transducers and activators of transcription) and induction of cytokine RANTES in H. pylori-infected gastric epithelial AGS cells. Since NADPH oxidase is a candidate for the production of reactive oxygen species in H. pylori-infected gastric epithelial cells, we determined the effect of 15d-PGJ(2) on the activation of NADPH oxdase. AGS cells were cultured in the presence of H. pylori treated with or without 15d-PGJ(2). The activations of NADPH oxidase and Jak1/Stat3, the levels of H(2)O(2) and RANTES in the medium, and DNA binding activity of Stat3 were assessed. A Jak/Stat3 specific inhibitor AG490 and an inhibitor of NADPH oxidase diphenyleneiodonium (DPI) were treated to determine the direct involvement of Jak/Stat and NADPH oxidase on the production of H(2)O(2) and RANTES in H. pylori-infected cells. H. pylori induced the production of H(2)O(2) and RANTES as well as the activations of NADPH oxidase and Jak1/Stat3, which were inhibited by the treatment of 15d-PGJ(2). DPI suppressed H. pylori-induced alterations similar to 15d-PGJ(2). However, AG490 had no effect on NADPH oxidase activation, but reduced the level of RANTES in the medium released from H. pylori-infected cells. Conclusion: NADPH oxidase activation is an upstream signaling of Jak1/Stat3 activation and induction of RANTES in H. pylori-infected AGS cells. 15d-PGJ(2), inhibits the activations of NADPH oxidase and Jak1/Stat3 and RANTES expression, suggesting that 15d-PGJ(2) may be beneficial for the treatment of H. pylori-induced gastric inflammation.-
dc.description.statementOfResponsibilityopen-
dc.format.extent167~174-
dc.relation.isPartOfJOURNAL OF PHYSIOLOGY AND PHARMACOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnti-Bacterial Agents/therapeutic use-
dc.subject.MESHCell Line, Tumor-
dc.subject.MESHChemokine CCL5/antagonists & inhibitors*-
dc.subject.MESHChemokine CCL5/biosynthesis-
dc.subject.MESHDown-Regulation/physiology*-
dc.subject.MESHEpithelial Cells/enzymology-
dc.subject.MESHEpithelial Cells/metabolism*-
dc.subject.MESHEpithelial Cells/microbiology-
dc.subject.MESHGastric Mucosa/enzymology-
dc.subject.MESHGastric Mucosa/metabolism*-
dc.subject.MESHGastric Mucosa/microbiology-
dc.subject.MESHHelicobacter Infections/enzymology-
dc.subject.MESHHelicobacter Infections/metabolism*-
dc.subject.MESHHelicobacter Infections/therapy-
dc.subject.MESHHelicobacter pylori-
dc.subject.MESHHumans-
dc.subject.MESHNADPH Oxidases/antagonists & inhibitors*-
dc.subject.MESHNADPH Oxidases/metabolism-
dc.subject.MESHProstaglandin D2/analogs & derivatives*-
dc.subject.MESHProstaglandin D2/physiology-
dc.subject.MESHProstaglandin D2/therapeutic use-
dc.title15-deoxy-D12,14-prostaglandin J2 suppresses RANTES expression by inhibiting NADPH oxidase activation in Helicobacter pylori-infected gastric epithelial cells-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pharmacology (약리학)-
dc.contributor.googleauthorB. CHA-
dc.contributor.googleauthorJ.W. LIM-
dc.contributor.googleauthorK.H. KIM-
dc.contributor.googleauthorH. KIM-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00311-
dc.relation.journalcodeJ01711-
dc.identifier.eissn1899-1505-
dc.identifier.pmid21673364-
dc.subject.keyword15 deoxy-∆12,14-
dc.subject.keywordprostaglandin J2-
dc.subject.keywordhuman stomach adenocarcinoma (AGS) cells-
dc.subject.keywordHelicobacter pylori-
dc.subject.keywordnicotinamide adenine dinucleotide phosphate (NADPH) oxidase-
dc.subject.keywordRANTES-
dc.contributor.alternativeNameKim, Kyung Hwan-
dc.contributor.affiliatedAuthorKim, Kyung Hwan-
dc.rights.accessRightsfree-
dc.citation.volume62-
dc.citation.number2-
dc.citation.startPage167-
dc.citation.endPage174-
dc.identifier.bibliographicCitationJOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, Vol.62(2) : 167-174, 2011-
dc.identifier.rimsid27169-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pharmacology (약리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.